Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Names Schultz To Head New Institute For Functional Genomics


LA JOLLA, Calif.--Peter Schultz, a professor of chemistry at University of California, Berkeley, has been named head of the new Novartis Institute for Functional Genomics here. Novartis announced in April that it will invest a total of $250 million over 10 years in the institute, which will be located adjacent to the new Novartis Agricultural Discovery Institute and Scripps Research Institute.

Schultz said he will equip a group of highly creative chemists, biologists, and engineers with powerful new genomic and chemical technologies to establish the institute as a world-class leader in bio medical research. Schultz has 15 years experience in organic chemistry and biomedical research, has won a number of awards, and is a member of the National Academy of Sciences. He will assume the new post January 1.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.